The content on this site is intended for healthcare professionals only
The Oncopolicy Roundtable: ECCO's President and special guests highlight key iss...
ECCO 15 - ESMO 34
22 Jul 2009
Targeting death receptors in chemo-resistant cancer cells
Prof Patrick Johnston - Queen's University Belfast, UK
3 Jul 2009
PSA/Prostate screening
Dr. Otis W. Brawley - Chief Medical Officer, ASCO
25 Jun 2009
Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
25 Jun 2009
AACR 2009: Circulating tumour cells as biomarkers
Dr Howard Scher - Sloan Kettering Memorial Cancer Center
5 Jun 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
14 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
14 May 2009
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
14 May 2009
AACR 2009: DNA profiling for bladder cancer
Dr Gangning Liang - Associate Professor of Research, Department of Urology, Univ...
30 Apr 2009
AACR 2009: Genetic prostate cancer risk
Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA
30 Apr 2009
AACR 2009: Designer T-Cells tackle prostate cancer
Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston...
30 Apr 2009
